- Home
- ECOR vs SYT Comparison
ECOR vs SYT Comparison
Compare ECOR & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- SYT
- Stock Information
- Founded
- ECOR 2005
- SYT 2010
- Country
- ECOR United States
- SYT Japan
- Employees
- ECOR N/A
- SYT N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SYT Real Estate
- Sector
- ECOR Health Care
- SYT Finance
- Exchange
- ECOR Nasdaq
- SYT Nasdaq
- Market Cap
- ECOR 40.1M
- SYT 41.2M
- IPO Year
- ECOR 2018
- SYT 2023
- Fundamental
- Price
- ECOR $6.02
- SYT $2.21
- Analyst Decision
- ECOR Strong Buy
- SYT
- Analyst Count
- ECOR 2
- SYT 0
- Target Price
- ECOR $25.50
- SYT N/A
- AVG Volume (30 Days)
- ECOR 130.4K
- SYT 4.8K
- Earning Date
- ECOR 05-07-2025
- SYT 04-29-2025
- Dividend Yield
- ECOR N/A
- SYT 0.28%
- EPS Growth
- ECOR N/A
- SYT N/A
- EPS
- ECOR N/A
- SYT 0.08
- Revenue
- ECOR $25,182,000.00
- SYT $149,124,408.00
- Revenue This Year
- ECOR $32.20
- SYT N/A
- Revenue Next Year
- ECOR $46.27
- SYT N/A
- P/E Ratio
- ECOR N/A
- SYT $27.87
- Revenue Growth
- ECOR 57.09
- SYT 3.11
- 52 Week Low
- ECOR $5.02
- SYT $1.18
- 52 Week High
- ECOR $19.49
- SYT $6.10
- Technical
- Relative Strength Index (RSI)
- ECOR 33.07
- SYT 65.10
- Support Level
- ECOR $5.20
- SYT $2.04
- Resistance Level
- ECOR $6.47
- SYT $2.24
- Average True Range (ATR)
- ECOR 0.71
- SYT 0.08
- MACD
- ECOR 0.33
- SYT 0.01
- Stochastic Oscillator
- ECOR 49.26
- SYT 82.61
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About SYT SYLA Technologies Co. Ltd.
SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.